Core Viewpoint - Goldwind Technology (02208) has seen a significant stock price increase, with a recent rise of over 6%, currently trading at 13.47 HKD, with a transaction volume of 1.44 billion HKD [1] Group 1: Project Announcement - Goldwind Technology announced plans to initiate a 3GW wind-hydrogen-ammonia integrated project in Urat Qianqi, with a total investment of approximately 18.92 billion RMB [1] - The project aims to construct 3GW of wind power, with over 80% of the generated electricity used for electrolysis to produce green hydrogen, resulting in the production of 600,000 tons of green methanol and 400,000 tons of green ammonia annually [1] Group 2: Market Analysis - According to Ping An Securities, the hydrogen-ammonia-methanol business is essentially an extension of the power station business [1] - In light of the implementation of Document No. 136, there were initial concerns regarding the development prospects of wind turbine companies' power station businesses; however, with policy support for green liquid fuels and increased investments in hydrogen-ammonia-methanol, the outlook for wind turbine companies' power station businesses has improved [1] - The firm believes that wind turbine manufacturers are currently experiencing a turning point in profitability for domestic wind turbine manufacturing, are about to realize performance gains from overseas expansion, and are benefiting from the incremental growth in hydrogen-ammonia-methanol within the power station business, creating a favorable investment opportunity for wind power equipment manufacturers [1]

Group 1: Investment and Fundraising - Hanyu Pharmaceutical plans to raise no more than 968 million yuan for the development of semaglutide and other projects [1] - Ganfeng Lithium intends to introduce investors for a capital increase of up to 2.5 billion yuan [9] Group 2: Strategic Restructuring - Pingmei Shenma Holdings is undergoing a strategic restructuring as directed by the Henan provincial government, which will not affect the company's operations significantly [2][8] - Shennong Holdings is also involved in a strategic restructuring with no change in control or significant impact on operations [7][8] Group 3: Clinical Trials and Approvals - XinNuoWei's subsidiary received approval for clinical trials of a drug for treating mild Alzheimer's disease, marking a significant milestone in the development of biosimilar drugs [3] - Tainkang's subsidiary has received approval for clinical trials of CKBA cream for rosacea, a first-class innovative drug in China [4] - Baili Tianheng's drug, iza-bren, has been included in the list of breakthrough therapies, indicating its potential in treating advanced urinary tract cancer [5] Group 4: Contracts and Projects - Zhongyou Engineering signed an EPC contract worth 2.524 billion USD for a seawater pipeline project in Iraq, expected to positively impact future revenues [6]

Core Viewpoint - On September 25, no A-share listed companies disclosed any increase in shareholding, while 16 companies announced share reductions, indicating a trend of shareholder divestment in the market [1]. Summary by Category Share Reduction Details - Hanghua Co. plans to reduce up to 4.24 million shares of repurchased stock to supplement working capital [2] - Weili Sealing's shareholders plan to reduce up to 1% of the company's shares [2] - Milkewei's actual controller and shareholders intend to collectively reduce up to 4.02% of the company's shares [2] - Zhichun Technology's controlling shareholder reduced 4.2678 million shares on September 25 [2] - Xinao Micro's senior management plans to reduce up to 0.0134% of the company's shares [2] - Quanfeng Technology's Hesheng Health Insurance reduced 57.1419 million shares from September 22 to September 24 [2] - Morning Light Biological's senior management Li Fengfei plans to reduce up to 140,000 shares [2] - Everbright Jiabao's Jiading Jianye and Jiading Keti plan to reduce up to 1% of their shares [2] - Shengshi Technology's employee stock ownership platform plans to reduce up to 3% of the company's shares [2] - Xingsen Technology's actual controller Qiu Xingya reduced a total of 9.9639 million shares from August 5 to September 22 [2] - Haizheng Materials' Sinopec Capital plans to reduce up to 2.0267 million shares, accounting for 1% of the total share capital [2] - Zhengzhong Design's controlling shareholder plans to reduce up to 3% of the company's shares [2] - Baiya Co.'s three shareholders plan to collectively reduce up to 2% of the company's shares [2] - Jialiqi's shareholders plan to collectively reduce up to 3% of the company's shares [2] - Defu Technology's shareholders plan to collectively reduce up to 0.13% of the company's shares [2] - Jinyinhe's shareholders plan to reduce up to 0.35% of the company's total share capital [2] Market Signal - The MACD golden cross signal has formed, indicating a positive trend for certain stocks [1]

格隆汇9月25日丨金风科技(002202.SZ)公布，收到股东和谐健康保险股份有限公司-万能产品（简称"和 谐健康"）出具的《关于减持股份触及1%整数倍的告知函》，和谐健康于2025年9月22日至2025年9月24 日期间通过集中竞价方式累计减持公司股份57,141,854股，占公司总股本的比例为1.352448%，占剔除 公司回购专用账户中的股份数量后总股本的比例为1.353354%。本次权益变动后，和谐健康持有公司股 份数量由422,506,671股减少至365,364,817股，占公司总股本的比例由9.999998%减少至8.647550%，占 剔除公司回购专用账户中股份数量后总股本的比例由10.006696%减少至8.653342%，权益变动触及1%的 整数倍。 ...

Core Viewpoint - The company, Goldwind Technology, reported a significant reduction in shareholding by Harmony Health Insurance Co., Ltd., which has implications for the company's ownership structure and potential market perception [1] Group 1: Shareholding Changes - Harmony Health reduced its shareholding in Goldwind Technology by 57,141,854 shares, representing 1.352448% of the total share capital [1] - Following this reduction, Harmony Health's total shareholding decreased from 422,506,671 shares to 365,364,817 shares, lowering its ownership percentage from 9.999998% to 8.647550% [1] - The reduction also affected the percentage of shares held after excluding the company's repurchase account, changing from 10.006696% to 8.653342% [1]

智通财经APP讯，金风科技(02208)公布，2025年9月25日，公司收到股东和谐健康保险股份有限公司-万 能产品(以下简称"和谐健康")出具的《关于减持股份触及1%整数倍的告知函》，和谐健康于2025年9月 22日至 2025年9月24日期间通过集中竞价方式累计减持公司股份57,141,854 股，占公司总股本的比例为 1.352448%，占剔除公司回购专用账户中的股份数量后总股本的比例为1.353354%。 本次权益变动后，和谐健康持有公司股份数量由422,506,671股减少至365,364,817股，占公司总股本的比 例由9.999998%减少至8.647550%，占剔除公司回购专用账户中股份数量后总股本的比例由10.006696% 减少至8.653342%，权益变动触及1%的整数倍。 ...

本公告乃根據《香港聯合交易所有限公司證券上市規則》第13.10B條而作出。 茲載列金風科技股份有限公司在深圳證券交易所網站刊登的《金風科技股份有限 公司關於持股 5%以上股東權益變動觸及 1%整數倍的公告》，僅供參閱。 ( 於中華人民共和國註冊成立的股份有限公司 ) (Stock Code: 02208) 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 GOLDWIND SCIENCE&TECHNOLOGY CO., LTD.* 金風科技股份有限公司 海外監管公告 公司股东和谐健康保险股份有限公司-万能产品保证向本公司 提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述 或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提 供的信息一致。 2025年9月25日，金风科技（以下简称"公司"）收到股东和谐健 康保险股份有限公司-万能产品（以下简称"和谐健康"）出具的《关 于减持股份触及1%整数倍的告知函》，和谐健康于2025年9月22 ...

特此公告。 本公司及董事会全体成员保证公告内容与信息披露义务人提 供的信息一致。 2025年9月25日，金风科技（以下简称"公司"）收到股东和谐健 康保险股份有限公司-万能产品（以下简称"和谐健康"）出具的《关 于减持股份触及1%整数倍的告知函》，和谐健康于2025年9月22日至 2025年9月24日期间通过集中竞价方式累计减持公司股份57,141,854 股，占公司总股本的比例为1.352448%，占剔除公司回购专用账户中 的股份数量后总股本的比例为1.353354%。本次权益变动后，和谐健 康持有公司股份数量由422,506,671股减少至365,364,817股，占公司总 股本的比例由9.999998%减少至8.647550%，占剔除公司回购专用账 户中股份数量后总股本的比例由10.006696%减少至8.653342%，权益 变动触及1%的整数倍。具体情况如下： | 1.基本情况 | | | | | | --- | --- | --- | --- | --- | | 信息披露义务人 | 和谐健康保险股份有限公司-万能产品 | | | | | 住所 | 中国（四川）自由贸易试验区成都高新区天府大道北段 ...

Core Viewpoint - Harmony Health Insurance Co., Ltd. reduced its stake in Goldwind Technology (002202.SZ) by selling 57,141,854 shares, representing 1.352448% of the company's total share capital, which indicates a significant change in shareholder structure [1] Summary by Relevant Sections - **Shareholder Action** - Harmony Health Insurance sold a total of 57,141,854 shares of Goldwind Technology from September 22 to September 24, 2025 [1] - Following this transaction, Harmony Health's shareholding decreased to 365,364,817 shares, which now constitutes 8.647550% of the total share capital [1]

Group 1 - China has achieved its 2020 wind and solar installation target six years ahead of schedule, with a new goal set to reach 3.6 billion kilowatts by 2035, which is six times the 2020 target [1][2] - The renewable energy sector has seen significant market performance, with solar equipment and energy storage indices showing positive growth, indicating investor confidence in the sector [1] - The total installed capacity of renewable energy in China reached 2.68 million kilowatts in the first half of this year, accounting for 91.5% of new installations, and the total capacity reached 2.159 billion kilowatts, representing a year-on-year growth of 30.6% [3] Group 2 - The new installation targets for wind and solar energy are seen as a strategic arrangement for optimizing China's energy structure and contributing positively to global climate governance [2] - The demand for energy in various sectors such as industry, construction, and transportation is expected to continue growing, driven by the electrification trend and the rapid adoption of digital technologies [2] - Renewable energy is projected to maintain its dominant position in new installations, constituting nearly 60% of the total installed capacity in the country [3]